Cerium oxide nanoparticle modulates hepatic damage, inflammatory and oxidative stress biomarkers in a dose-dependent manner: an in vivo study of rat liver

Document Type: Research Paper

Authors

1 Department of Toxicology and Pharmacology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran

2 Abadan School of Medical Sciences, Abadan, Iran

3 Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical ciences, Kashan, Iran

Abstract

Objective (s): Cerium oxide nanoparticles nanoceria (CeNPs) is a novel nanoparticle that has great potential for the treatment of various diseases. This study aimed to investigate the effects of CeNPs on oxidative stress biomarkers in the liver of male rats.
Materials and Methods: Twenty-four male Wistar rats were equally distributed into 4 groups (n=6/each). The first group was controlled and the next three groups received CeNPs (15, 30 and 60 mg/kg/day), with an intraperitoneal injection (IP) for 7 days. After treatment, serum and liver tissue was isolated. ALT and AST concentration, total antioxidant capacity (TAC), total thiol molecules (TTM), interleukin 17 (IL-17), nitric oxide (NO) and TNF-α were measured.
Results: CeNPs 30, 60 mg/kg caused a significant increased NO (P=0.03, P=0.001), TNF-α (P=0.03, P=0.01) and IL-17 (P=0.04, P=0.01) levels, compared with the control group. Also CeNPs caused a decrease in the TTM (P=0.002) and increased MDA (P=0.04) in 60 mg/kg group compared to the control group. CeNPs 15 mg/kg significantly suppressed mainly the increase in plasma activities of aminotransferases (ALT (P=0.001), AST (P=0.01)), and liver IL-17 (P=0.01) and NO (P=0.02) concentrations compared to the control group.
Conclusion: These results suggest that the effects of CeNPs are dose-dependent and at 15 mg/kg dose, it may have protective effects. Moreover, CeNPs in 30 and 60mg/kg doses showed immunotoxicity and oxidative effects in the liver.

Keywords


1. Moridi H, Hosseini SA, Shateri H, Kheiripour N, Kaki A, Hatami M, Ranjbaran A: Protective effect of cerium oxide nanoparticle on sperm quality and oxidative damage in malathion-induced testicular toxicity in rats: An experimental study. Int J Reprod BioMed. 2018; 16(4):261-266.
2. Dunnick KM, Pillai R, Pisane KL, Stefaniak AB, Sabolsky EM, Leonard SS: The effect of cerium oxide nanoparticle valence state on reactive oxygen species and toxicity. Biol Trace Elem Res. 2015; 166(1): 96-107.
3. Park E-J, Choi J, Park Y-K, Park K: Oxidative stress induced by cerium oxide nanoparticles in cultured BEAS-2B cells. Toxicology. 2008; 245(1): 90-100.
4. Niu J, Wang K, Kolattukudy PE: Cerium oxide nanoparticles inhibits oxidative stress and nuclear factor-κB activation in H9c2 cardiomyocytes exposed to cigarette smoke extract. J Pharmacol Exp Ther. 2011; 338(1): 53-61.
5. Park E-J, Yi J, Chung K-H, Ryu D-Y, Choi J, Park K: Oxidative stress and apoptosis induced by titanium dioxide nanoparticles in cultured BEAS-2B cells. Toxicol Lett. 2008; 180(3): 222-229.
6. Carnovale CE, Ronco MT: Role of nitric oxide in liver regeneration. Ann Hepatol. 2012; 11(5): 636-647.
7. Abdelmegeed MA, Song B-J: Functional roles of protein nitration in acute and chronic liver diseases. Oxid Med Cell Longev. 2014; 2014.
8. Kheiripour N, Karimi J, Khodadadi I, Tavilani H, Goodarzi MT, Hashemnia M: Silymarin prevents lipid accumulation in the liver of rats with type 2 diabetes via sirtuin1 and SREBP-1c. J Basic Clin Physiol Pharmacol. 2018; 29(3): 301-308.
9. Wheeler MD, Kono H, Yin M, Nakagami M, Uesugi T, Arteel GE, Gäbele E, Rusyn I, Yamashina S, Froh M: The role of kupffer cell oxidant production in early ethanol-induced liver disease 1,2. Free Radic Biol Med. 2001; 31(12): 1544-1549.
10. Iwakura Y, Ishigame H, Saijo S, Nakae S: Functional specialization of interleukin-17 family members Immunity. 2011; 34(2): 149-162.
11. Jin W, Dong C: IL-17 cytokines in immunity and inflammation. Emerg Microbes Infect. 2013; 2(9): e60.
12. Sarkar A, Ghosh M, Sil PC: Nanotoxicity: oxidative stress mediated toxicity of metal and metal oxide nanoparticles. J Nanosci Nanotechnol. 2014; 14(1): 730-743.
13. Pagliari F, Mandoli C, Forte G, Magnani E, Pagliari S, Nardone G, Licoccia S, Minieri M, Di Nardo P, Traversa E: Cerium oxide nanoparticles protect cardiac progenitor cells from oxidative stress. ACS nano. 2012; 6(5): 3767-3775.
14. Benameur L, Auffan M, Cassien M, Liu W, Culcasi M, Rahmouni H, Stocker P, Tassistro V, Bottero J-Y, Rose Jm: DNA damage and oxidative stress induced by CeO2 nanoparticles in human dermal fibroblasts: Evidence of a clastogenic effect as a mechanism of genotoxicity. Nanotoxicol. 2015; 9(6): 696-705.
15. Schubert D, Dargusch R, Raitano J, Chan S-W: Cerium and yttrium oxide nanoparticles are neuroprotective. Biochem Biophys Res Commun. 2006; 342(1): 86-91.
16. Benzie IF, Strain J:[2] Ferric reducing/antioxidant power assay: Direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol. 1999; 299:15-27.
17. Rahimi R, Karimi J, Khodadadi I, Tayebinia H, Kheiripour N, Hashemnia M, Goli F: Silymarin ameliorates expression of urotensin II (U-II) and its receptor (UTR) and attenuates toxic oxidative stress in the heart of rats with type 2 diabetes. Biomed Pharmacother. 2018; 101: 244-250.
18. Draper HH, Hadley M: Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 1990; 186: 421-431.
19. Powell CS, Jackson RM: Mitochondrial complex I, aconitase, and succinate dehydrogenase during hypoxia-reoxygenation: modulation of enzyme activities by MnSOD. Am J Physiol Lung Cell Mol Physiol. 2003; 285(1): L189-L198.
20. Xu C, Qu X: Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications. NPG Asia Materials. 2014; 6(3): e90.
21. Gao Y, Chen K, Ma J-l, Gao F: Cerium Oxide Nanoparticles in Cancer . OncoTargets Ther. 2014; (7): 835–840.
22. Vinardell MP, Mitjans M: Antitumor activities of metal oxide nanoparticles. Nanomaterials. 2015; 5(2):1004-1021.
23. Amin KA, Hassan MS, Awad E-ST, Hashem KS: The protective effects of cerium oxide nanoparticles against hepatic oxidative damage induced by monocrotaline. Int J Nanomedicine. 2011; 6(17): 143-149.
24. Wason MS, Zhao J: Cerium oxide nanoparticles: potential applications for cancer and other diseases. Am J Transl Res. 2013; 5(2): 126-131.
25. Seth V, Banerjee BD, Bhattacharya A, Pasha ST, Chakravorty AK: Pesticide induced alterations in acetylcholine esterase and gamma glutamyl transpeptidase activities and glutathione level in lymphocytes of human poisoning cases. Clin Biochem. 2001; 34(5): 427-429.
26. Kim W, Flamm SL, Di Bisceglie AM, Bodenheimer HC: Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology. 2008; 47(4): 1363-1370.
27. Ibrahim MA, Khalaf A, Galal MK, Ogaly HA, Hassan AH: Ameliorative influence of green tea extract on copper nanoparticle-induced hepatotoxicity in rats. Nanoscale Res Lett. 2015; 10(1): 363.
28. Caride A, Lafuente A, Cabaleiro T: Endosulfan effects on pituitary hormone and both nitrosative and oxidative stress in pubertal male rats. Toxicol lett. 2010; 197(2): 106-112.
29. Rodríguez-Ortigosa CM, Celay J, Olivas I, Juanarena N, Arcelus S, Uriarte I, Marín JJG, Avila MA, Medina JF, Prieto J:A GAPDH-mediated trans-nitrosylation pathway is required for feedback inhibition of bile salt synthesis in rat liver. Gastroenterology. 2014; 147(5): 1084-1093.
30. Kvietys PR, Granger DN: Role of reactive oxygen and nitrogen species in the vascular responses to inflammation. Free Radic Biol Med. 2012; 52(3):556-592.
31. Iwakiri Y, Kim MY: Nitric oxide in liver diseases. Trends Pharmacol Sci. 2015; 36(8): 524-536.
32. Rollin-Genetet Fo, Seidel C, Artells E, Auffan Ml, Thiéry A, Vidaud C: Redox Reactivity of Cerium Oxide Nanoparticles Induces the Formation of Disulfide Bridges in Thiol-Containing Biomolecules. Chem Res Toxicol. 2015; 28(12): 2304-2312.
33. Diesen DL, Kuo PC: Nitric oxide and redox regulation in the liver: part II. Redox biology in pathologic hepatocytes and implications for intervention. J Surg Res. 2011; 167(1):96-112.
34. Circu ML, Aw TY: Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med. 2010; 48(6): 749-762.
35. Green DR, Kroemer G: The pathophysiology of mitochondrial cell death. Science. 2004; 305(5684): 626-629.
36. Krähenbühl S, Talos C, Lauterburg BH, Reichen J: Reduced antioxidative capacity in liver mitochondria from bile duct ligated rats. Hepatology. 1995; 22(2): 607-612.
37. Marí M, Caballero F, Colell A, Morales A, Caballeria J, Fernandez A, Enrich C, Fernandez-Checa JC, García-Ruiz C: Mitochondrial free cholesterol loading sensitizes to TNF-and Fas-mediated steatohepatitis. Cell Metab. 2006; 4(3):185-198.
38. Eom HJ, Choi J: Oxidative stress of CeO2 nanoparticles via p38-Nrf-2 signaling pathway in human bronchial epithelial cell, Beas-2B. Toxicol Lett. 2009; 187(2):77-83.
39. Celardo I, Pedersen JZ, Traversa E, Ghibelli L: Pharmacological potential of cerium oxide nanoparticles. Nanoscale. 2011; 3(4): 1411-1420.